ReviewArchives of microbiology2026
Microbial lipases: advances in metagenomics and artificial intelligence for enzyme discovery and engineering.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microbial lipases are versatile biocatalysts with high catalytic efficiency, substrate specificity, stability, and ability to catalyze a wide range of processes under mild environmental conditions, which make them highly valuable in various industrial and biotechnological applications. However, traditional methods of enzyme discovery and engineering rely on cultured microorganisms and labor-intensive experimental processes. This study highlights recent developments in metagenomics and AI technologies for microbial lipase discovery and engineering and providing a brief overview of the sources, structural features, physicochemical properties, and industrial applications of lipases. Recent breakthroughs in metagenomics have provided new access to novel enzymes from non-cultivable microbial communities, and the rising significance of artificial intelligence in enzyme discovery, structure prediction, protein engineering, and bioprocess optimization is presented. This study also highlights the important synergy between metagenomics and artificial intelligence technologies for the identification and rational design of enzymes, integrating extensive sequence databases with predictive computational modeling tools. In addition, there are still various challenges, such as low heterologous expression levels, a lack of quality information, and limited industrial-scale validation. We anticipate that future advances in protein language models, generative artificial intelligence, synthetic biology, and multi-omics integration will accelerate enzyme discovery, engineering, and large-scale industrial implementation. Overall, the use of metagenomics, artificial intelligence, and experimental approaches has tremendous potential for developing efficient and economically viable lipases for sustainable biotechnological applications.
Indexed as
Identifiers
42565866What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.